Table 2 Comparison of baseline and post-treatment SUV in both responder and non-responder groups
From: Role of PET/CT in post-therapeutic assessment of bronchogenic carcinoma
Responder group (n = 8) | Non-responder group (n = 12) | |||||
|---|---|---|---|---|---|---|
Pre-treatment | Post-treatment | P-value | Pre-treatment | Post-treatment | P-value | |
SUV | ||||||
Median | 14.6 | 5.6 | 10.9 | 11.8 | ||
IQR | 11.8–17.7 | 2.8–6.3 | 0.008 | 4.95–20.7 | 6.3–19.4 | 0.638 |
Range | 10–20 | 0–8 | 3.5–34.7 | 2–28.2 | ||